Insights Into Participating in Studies for Uterine Cancer
Not yet recruiting
- Conditions
- Uterine Cancer
- Registration Number
- NCT05998811
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical study participation has historically been heavily biased toward specific demographics.
Several people will be invited to enroll in this trial so that it may collect a variety of data about uterine cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.
People with uterine cancer who are invited to take part in medical study will benefit from the analysis of the data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Diagnosis of uterine cancer
- No prior treatment for uterine cancer
Exclusion Criteria
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Enrolled in another research study
- Inability to provide written informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to enroll in a uterine cancer clinical research 3 months Rate of patients who remain in a uterine cancer clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States